That combination is why the weight loss numbers look the way they do
Oral antidiabetic medication was discontinued 3 weeks prior to the study
CrossRef Identification of novel circulating protein biomarkers for hepatocellular carcinoma superior to alpha-fetoprotein through a stemness index and secretome analysis Cai Gao, Xuebing Li, Xinwei Liu, Sha Yan, Xiaodan Ran, Jingxian Han World Journal of Surgical Oncology .2026;[Epub] CrossRef NOP56 interacts with Fibrarin to regulate the PI3K/AKT signaling pathway and inhibit apoptosis of hepatocellular carcinoma Hongwei Chen, Xinggang Fan, Di Cui Frontiers in Oncology .2026;[Epub] CrossRef Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF) Stefano Gitto, Filippo Gabrielli, Giovanni Addolorato, Claudia Tarli, Giacomo Zaccherini, Rosaria Calia, Giacomo Germani, Patrizia Burra, Alberto Zanetto, Francesca Ferri, Roberta DAmbrosio, Pierluigi Toniutto, Nicola Pugliese, Fiammetta Cosci, Giuseppe Digestive and Liver Disease .2026
The Switching Protocol If switching from semaglutide to tirzepatide: Take your last dose of semaglutide as scheduled Wait one week (your normal injection day) Start tirzepatide at the initial dose recommended by your provider Follow the prescribed titration schedule Start tirzepatide at the dose recommended by your provider, even if you were on a higher dose of semaglutide
